Eye health issues examined in Ophthalmology

Article

Three separate studies on eye health examine the role of antioxidant supplements, the relationship of visual acuity and mortality, and the causes of glaucoma in the May 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.

Three separate studies on eye health examine the role of antioxidant supplements, the relationship of visual acuity and mortality, and the causes of glaucoma in the May 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.

39,876 professional women aged 45 or more took 600 IU of vitamin E every other day and 100 mg of aspirin every day in the 10-year randomized, controlled Women's Health Study (WHS). Women who took vitamin E supplements had rates of cataract development comparable with women who did not take such supplements.

A study led by Tien Yin Wong, MD, PhD examined the correlation between eyesight and mortality. The study assessed 1,232 Chinese people living in Singapore, 10% of whom died; in this group, the death rate was found to be three times higher for people with 20/40 vision.

Evidence has been found to support the theory that low cerebrospinal fluid (CSF) pressure may be a significant contributor to optic nerve damage in glaucoma. Results of a study showed that between 1996 and 2007, 28 patients with primary open-angle glaucoma who had CSF samples taken by lumbar punctures had significantly lower pressure than controls.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.